# Phase IV Study of Concomitant Administration of the sIPV and HepA

> **NCT06460545** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Institute of Medical Biology, Chinese Academy of Medical Sciences** · enrollment: 2000 (estimated)

## Conditions studied

- Polio
- Hepatitis A

## Interventions

- **BIOLOGICAL:** sIPV (booster dose at 18 months of age)
- **BIOLOGICAL:** HepA-L
- **BIOLOGICAL:** HepA-I

## Key facts

- **NCT ID:** NCT06460545
- **Lead sponsor:** Institute of Medical Biology, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-15
- **Primary completion:** 2026-08-15
- **Final completion:** 2027-12-15
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2024-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06460545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06460545, "Phase IV Study of Concomitant Administration of the sIPV and HepA". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06460545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*